Effect of Siddha medicines in post COVID-19 patients at Sri Nallamani Siddha Covid centre, Tenkasi District, TamilNadu - A Cross Sectional Study

EFFECT OF AROKYAM KIT ( SIDDHA CONVALESCENCE MEDICINES) IN PATIENTS TREATED AT SRI NALLAMANI SIDDHA COVID CARE CENTER, TENKASI DISTRICT, TAMIL NADU - A CROSS SECTIONAL STUDY

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/035028

Enrollment

1409

Registered

2021-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Amukkura chooranam tablet each tablet 500mgs.: Two tablet, Two times a day, after food, with hot water The medicine is taken for 25 days. Intervention2: Nellikai legiyam: 5 grams, two t

Eligibility

Inclusion criteria

Inclusion criteria: Post covid 19 convalescence treatment for the period of 15 days

Exclusion criteria

Exclusion criteria: below 12 yrs and above 85 yrs. antenatal mothers were excluded Malignancy conditions Psychiatric groups

Design outcomes

Primary

Measure	Time frame
To Prevent and reduce the post COVID 19 complicationsTimepoint: 15 days	—

Secondary

Measure	Time frame
To Prevent and reduce the post COVID 19 complicationsTimepoint: 15 days	—

Countries

India

Contacts

Public ContactS Bosepriyan

Directorate of Indian Medicine

chenthurvenkat@gmail.com9442180895

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026